OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 3.696
-0.126 (-3.30%)
Jun 3, 2026, 5:35 PM CET
OSE Immunotherapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, OSE Immunotherapeutics stock has a consensus rating of "Strong Buy" and an average price target of €14.07. The average 1-year stock price forecast is 280.68% higher than the current stock price, while the lowest is €8.20 (+121.86%) and the highest is €21.00 (+468.18%).
Price Target: €14.07 (+280.68%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 30, 2026.
Analyst Ratings
The average analyst rating for OSE Immunotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Dec '25 | Jan '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Kepler Capital | Kepler Capital | Buy Maintains €8.20 | Buy | Maintains | €8.20 | +121.86% | Apr 30, 2026 |
Financial Forecast
Revenue This Year
8.68M
from 1.78M
Increased by 386.81%
Revenue Next Year
11.54M
from 8.68M
Increased by 33.03%
EPS This Year
-1.11
from -1.48
EPS Next Year
-1.20
from -1.11
Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.0M | ||
| Avg | 8.7M | ||
| Low | 1.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,078.5% | ||
| Avg | 386.8% | ||
| Low | -15.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.35 | ||
| Avg | -1.11 | ||
| Low | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.